Organicell Regenerative Medicine, Inc. reported earnings results for the first quarter ended January 31, 2023. For the first quarter, the company reported sales was USD 1.07 million compared to USD 1.6 million a year ago. Net loss was USD 2.29 million compared to USD 1.69 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -3.85% | -14.62% | +22.55% |
Mar. 18 | Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Mar. 05 | Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.55% | 7.96M | |
+15.79% | 71.39B | |
+2.09% | 25.1B | |
-1.22% | 8.59B | |
+7.95% | 8.19B | |
-20.48% | 7.91B | |
+15.26% | 4.31B | |
-1.24% | 3.93B | |
-3.02% | 3.86B | |
+21.10% | 3.64B |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023